scholarly journals Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19

2021 ◽  
Author(s):  
Jihad Inshasi ◽  
Raed Alroughani ◽  
Abdullah Al-Asmi ◽  
Jaber Alkhaboury ◽  
Abdullah Alsalti ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Arabian Gulf ◽  
Narrative Review ◽  
Expert Consensus ◽  
Disease Modifying Therapies ◽  
Disease Modifying

scholarly journals The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review

CNS Drugs ◽  
2021 ◽  
Author(s):  
Marco Biolato ◽  
Assunta Bianco ◽  
Matteo Lucchini ◽  
Antonio Gasbarrini ◽  
Massimiliano Mirabella ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Liver Injury ◽  
Narrative Review ◽  
Disease Modifying Therapies ◽  
Relapsing Remitting ◽  
Disease Modifying ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

scholarly journals Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity

2020 ◽  
Vol 132 (4) ◽  
pp. 368-376 ◽  
Author(s):  
Raed Alroughani ◽  
Jihad Inshasi ◽  
Abdullah Al-Asmi ◽  
Abdulradha Alqallaf ◽  
Abdulla Al Salti ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Disease Activity ◽  
Arabian Gulf ◽  
Expert Consensus ◽  
Disease Modifying ◽  
Disease Modifying Treatment

scholarly journals Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis

2013 ◽  
Vol 19 (1 Supp A) ◽  
pp. S24-S40 ◽  
Author(s):  
Joseph Menzin ◽  
Christina Caon ◽  
Christine Nichols ◽  
Leigh Ann White ◽  
Mark Friedman ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Narrative Review ◽  
Review Of The Literature ◽  
Disease Modifying Therapies ◽  
Disease Modifying

Comparison of use oral and injection disease-modifying therapies in persons with multiple sclerosis

2018 ◽  
Author(s):  
taha aslan ◽  
Serkan Ozakbas ◽  
Asiye Tuba Ozdogar
Keyword(s):  
Multiple Sclerosis ◽  
Disease Modifying Therapies ◽  
Disease Modifying

scholarly journals Ethical use of off-label disease-modifying therapies for multiple sclerosis

2021 ◽  
pp. 135245852110302
Author(s):  
Joanna Laurson-Doube ◽  
Nick Rijke ◽  
Anne Helme ◽  
Peer Baneke ◽  
Brenda Banwell ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Clinical Decision Making ◽  
Clinical Decision ◽  
World Health ◽  
World Federation ◽  
Off Label ◽  
Disease Modifying Therapies ◽  
The World ◽  
Disease Modifying ◽  
Health Organization

Background: Off-label disease-modifying therapies (DMTs) for multiple sclerosis (MS) are used in at least 89 countries. There is a need for structured and transparent evidence-based guidelines to support clinical decision-making, pharmaceutical policies and reimbursement decisions for off-label DMTs. Objectives/Results: The authors put forward general principles for the ethical use of off-label DMTs for treating MS and a process to assess existing evidence and develop recommendations for their use. Conclusion: The principles and process are endorsed by the World Federation of Neurology (WFN), American Academy of Neurology (AAN), European Academy of Neurology (EAN), Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Middle-East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) and Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), and we have regularly consulted with the Brain Health Unit, Mental Health and Substance Use Department at the World Health Organization (WHO).

scholarly journals Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

2021 ◽  
Author(s):  
Maria P. Sormani ◽  
Nicola De Rossi ◽  
Irene Schiavetti ◽  
Luca Carmisciano ◽  
Cinzia Cordioli ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Disease Modifying Therapies ◽  
Disease Modifying
Sign in / Sign up

Export Citation Format

Share Document